Rachael Green

Rachael Green

Benzinga Staff Writer

About
Rachael Green is a New York-based freelance writer with a strong background in media and journalism, having worked as a reporter, associate producer, or writer for the past 9 years. She specializes in finance, health, business news, and politics with...
Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
Sponsored
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected mid-2024
Sponsored
Tiziana Expects To Start Enrolling Patients In Its Phase 2 Clinical Trial To Treat Secondary Progressive Multiple Sclerosis (SPMS) Using Its Novel Intranasal Monoclonal Antibody Foralumab
Sponsored
Active ETFs Appear Booming In 2023 — Tema ETFs Are Taking Them Into A New Direction
Sponsored
Steakholder's (NASDAQ: STKH) New Beef Ink Is Helping Make Commercial-Scale Steak Printing A Reality
Sponsored
Sprott ETF Product Management Director Steven Schoffstall Explains Why Uranium Prices Are Soaring This Year And How Investors Can Trade The Rally
Sponsored
3D Printed Steaks Could Be The Next Emerging Tech ESG Investors Should Be Watching – Here's Why
Sponsored
Sadot's Strategic Pivot Looks Like It's Paying Off As Analysts Forecast 360% Year-Over-Year Jump In Annual Revenue For 2023
Sponsored
Nearly A Third Of Advisors Are Seeking Alternative Investments For Their Clients — But A Self-Directed IRA Is Needed To Invest
Sponsored
HEVI's Cost-Effective All-Electric Heavy Equipment Could Be Key To Reaching Net Zero Emissions By 2050
Sponsored
New Hope For Long COVID Sufferers
Sponsored
Pet Owners Are Spending More And More On Vet Visits, Meds And Higher Quality Pet Food – Here Are The Key Trends Investors Should Watch
Sponsored
The Entrust Group Named Best Online Portal By Investopedia For Its One-Stop-Shop Platform For Managing Self-Directed IRAs
Sponsored
Nearly A Third Of Japan's 36 Million Seniors Are At Risk Of Aging Frailty – Could Lomecel-BTM, Longeveron's (NASDAQ: LGVN) Cell Therapy Help?
Sponsored
Charging Infrastructure Will Be Key To Electrifying The Heavy Equipment Industry – HEVI Is Making Portable Chargers To Deliver That Accessibility
Sponsored
Independent Clinical Study Confirms Cue Health's COVID-19 Test Is As Accurate As A Lab Test
Sponsored
This Sustainable Energy Company Just Landed A Deal To Build 40 Megawatts Of Solar Powered Microgrids For One of California's Largest Privately Owned Oil And Gas Company
Sponsored
This Encrypted Messenger App Could Help Wall Street Avoid New Fines Amid SEC Crackdown On FINRA Violations
Sponsored
FORME Eyes Sustainable Growth Through CLMBR Acquisition Using A B2B/B2C Multi-channel Strategy To 'Avoid Mistakes Of Peloton, Other Struggling Connected Fitness Companies'
Sponsored
Tiziana To Announce Six-Month Human Safety And Biomarker Data At The ECTRIMS Annual Congress, Following-Up From Positive Outcomes Data Presented In June
Sponsored